Filing Details
- Accession Number:
- 0001562180-19-003526
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-14 16:13:36
- Reporting Period:
- 2019-06-12
- Accepted Time:
- 2019-06-14 16:13:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1270905 | David Norman Eansor | 8100 Southpark Way, A-8 Littleton CO 80120 | Svp - Novus Biologicals | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-06-12 | 3,117 | $215.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | $0.00 | 2,287 | 2,287 | Direct | ||
| Common Stock | Restricted Stock Units | $0.00 | 2,174 | 2,174 | Direct | ||
| Common Stock | Restricted Stock Units | $0.00 | 2,537 | 2,537 | Direct | ||
| Common Stock | Stock Option (Right to Buy) | $108.49 | 2022-08-07 | 12,500 | 12,500 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $94.35 | 2021-08-12 | 15,000 | 15,000 | Direct | |
| Common Stock | Stock Options (Right to buy) | $177.32 | 2025-08-08 | 18,066 | 18,066 | Direct | |
| Common Stock | Stock Options (Right to buy) | $177.32 | 2025-08-08 | 13,550 | 13,550 | Direct | |
| Common Stock | Stock Options (Right to buy) | $125.05 | 2024-08-09 | 11,982 | 11,982 | Direct | |
| Common Stock | Stock Options (Right to buy) | $125.05 | 2024-08-09 | 15,976 | 15,976 | Direct | |
| Common Stock | Stock Options (Right to buy) | $108.49 | 2022-08-07 | 7,494 | 7,494 | Direct | |
| Common Stock | Stock Options (Right to buy) | $106.59 | 2023-08-18 | 18,819 | 18,819 | Direct | |
| Common Stock | Stock Options (Right to buy) | $106.59 | 2023-08-18 | 14,114 | 14,114 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2,287 | 2,287 | Direct | |
| 2,174 | 2,174 | Direct | |
| 2,537 | 2,537 | Direct | |
| 2022-08-07 | 12,500 | 12,500 | Direct |
| 2021-08-12 | 15,000 | 15,000 | Direct |
| 2025-08-08 | 18,066 | 18,066 | Direct |
| 2025-08-08 | 13,550 | 13,550 | Direct |
| 2024-08-09 | 11,982 | 11,982 | Direct |
| 2024-08-09 | 15,976 | 15,976 | Direct |
| 2022-08-07 | 7,494 | 7,494 | Direct |
| 2023-08-18 | 18,819 | 18,819 | Direct |
| 2023-08-18 | 14,114 | 14,114 | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2019.
- Vests 4,705 shares on 8/18/17, 8/18/18, and 8/18/19 and 4,704 shares on 8/18/20.
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- 3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
- Fully exercisable
- Vest 4,517 shares on each 8/8/2019, 8/9/2020 and 4,516 shares on 8/8/2021, 8/9/2022
- Vest 3,994 shares on each 8/9/2018, 8/9/2019, 8/9/2020, 8/9/2021
Billionaire Hedge Funds
